+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Assessment of late anthracycline-induced cardiotoxicity by 123 I-mIBG cardiac scintigraphy in patients treated during childhood and adolescence



Assessment of late anthracycline-induced cardiotoxicity by 123 I-mIBG cardiac scintigraphy in patients treated during childhood and adolescence



Journal of Nuclear Cardiology 24(1): 256-264



The goal of this study was to evaluate late cardiotoxic effects of anthracyclines (ATC) by evaluating cardiac sympathetic activity in a cohort of asymptomatic patients previously treated with ATC for childhood cancers. We studied 89 asymptomatic patients previously treated with ATC with a normal echocardiogram (49 men and 40 women) and a control group of 40 healthy individuals (26 men and 14 women). Both groups underwent planar myocardial 123I-meta-iodobenzylguanidine scintigraphy (123I-mIBG). From these images, the early and late heart-to-mediastinum (H/M) ratio and washout rate (WR) were assessed. The mean survival at the time of the 123I-mIBG scintigraphy was 5.3 ± 3.4 years. Patients treated with ATC had a lower but clinical normal left ventricular ejection fraction (LVEF) compared to controls (60.44 ± 6.5 vs 64.1 ± 6.0%, P < 0.01). Both the late H/M ratio and WR were not able to discriminate ATC treated patients from controls. The cumulative ATC dose was the only independent predictor of the LVEF, explaining approximately 12% of the variation in LVEF (P = 0.01). Although the pathophysiology behind ATC cardiotoxicity is most likely multifactorial, myocardial sympathetic activity is not associated with a reduction in LVEF 5-years after completion of chemotherapy.

(PDF emailed within 0-6 h: $19.90)

Accession: 057243710

Download citation: RISBibTeXText

PMID: 26601670

DOI: 10.1007/s12350-015-0309-y


Related references

Anthracycline-induced cardiotoxicity: Is there a role for myocardial 123I-mIBG scintigraphy?. Journal of Nuclear Cardiology 2019, 2019

Noninvasive identification of anthracycline cardiotoxicity: comparison of 123I-MIBG and 123I-BMIPP imaging. Annals of Nuclear Medicine 8(3): 177-182, 1994

Cardiac 123I-MIBG scintigraphy in patients with drug induced parkinsonism. Journal of Neurology, Neurosurgery, and Psychiatry 77(3): 372-374, 2005

123I-MIBG scintigraphy in cardiotoxicity related to antineoplastic agents. Kaku Igaku. Japanese Journal of Nuclear Medicine 31(5): 451-458, 1994

Early and late anthracycline-induced cardiotoxicity in childhood: non-invasive evaluation of contractility in 116 patients. Giornale Italiano di Cardiologia 25(10): 1295-1305, 1995

Anthracycline-induced acute cardiotoxicity in adults treated for leukaemia. Analysis of the clinico-pathological aspects of documented acute anthracycline-induced cardiotoxicity in patients treated for acute leukaemia at the University Hospital of Zürich, Switzerland, between 1990 and 1996. Annals of Oncology 12(7): 963-966, 2001

Use of 123I-MIBG scintigraphy to assess the impact of carvedilol on cardiac adrenergic neuronal function in childhood dilated cardiomyopathy. European Journal of Nuclear Medicine and Molecular Imaging 30(12): 1651-1656, 2003

Assessment of cardiac toxicity by 123I-MIBG myocardial SPECT in elderly non-Hodgkin lymphoma patients treated with COP-BLAM and G-CSF. Japanese Journal of Clinical Hematology 36(11): 1326-1328, 1995

Improvement of cardiac neuronal adrenergic function after carvedilol treatment assessed by 123I-MIBG scintigraphy in childhood dilated cardiomyopathy. Journal of Nuclear Medicine 44(5 Supplement): 185P, 2003

Cardiac 123I-MIBG scintigraphy in patients with essential tremor. Movement Disorders 21(8): 1235-1238, 2006

Diagnostic value of cardiac 123I-metaiodobenzylguanidine (123I-MIBG) scintigraphy in Lewy body disorders. Neurologia 24(3): 170-176, 2009

Cardiac sympathetic function in the patients with amyotrophic lateral sclerosis analysis using cardiac 123I MIBG scintigraphy. 2013

Cardiac sympathetic function in the patients with amyotrophic lateral sclerosis: analysis using cardiac [123I] MIBG scintigraphy. Journal of Neurology 260(9): 2380-2386, 2014

123I-ioflupane brain SPECT and 123I-MIBG cardiac planar scintigraphy combined use in uncertain parkinsonian disorders. Medicine 96(21): E6967, 2017

123I-MIBG for detection of subacute doxorubicin-induced cardiotoxicity in patients with malignant lymphoma. Journal of Nuclear Cardiology 2018, 2018